UBS Group Has Lowered Expectations for Select Medical (NYSE:SEM) Stock Price

Select Medical (NYSE:SEM - Get Free Report) had its price objective decreased by stock analysts at UBS Group from $40.00 to $21.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has a "neutral" rating on the health services provider's stock. UBS Group's price objective points to a potential upside of 14.13% from the stock's current price.

SEM has been the subject of a number of other reports. Benchmark cut Select Medical from a "buy" rating to a "hold" rating in a research note on Monday, November 25th. Royal Bank of Canada raised their price target on shares of Select Medical from $40.00 to $47.00 and gave the company an "outperform" rating in a report on Monday, November 4th. Finally, StockNews.com lowered shares of Select Medical from a "buy" rating to a "hold" rating in a research note on Monday. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, Select Medical has a consensus rating of "Hold" and a consensus price target of $39.50.

Select Medical Trading Down 2.1 %

SEM stock traded down $0.39 during trading on Friday, hitting $18.40. The company had a trading volume of 1,021,052 shares, compared to its average volume of 983,576. The firm has a market capitalization of $2.38 billion, a P/E ratio of 8.60, a PEG ratio of 0.39 and a beta of 1.43. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical has a 52-week low of $18.02 and a 52-week high of $40.98. The company has a 50 day simple moving average of $26.91 and a 200-day simple moving average of $32.21.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.07. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company's revenue was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.46 earnings per share. As a group, research analysts forecast that Select Medical will post 1.97 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of the company's stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the sale, the vice president now owns 30,356 shares in the company, valued at $605,602.20. This represents a 14.12 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of the firm's stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the transaction, the director now directly owns 22,000 shares of the company's stock, valued at $463,980. This represents a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 19.14% of the stock is owned by insiders.

Institutional Investors Weigh In On Select Medical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Quarry LP acquired a new position in shares of Select Medical in the 3rd quarter valued at $30,000. Canada Pension Plan Investment Board purchased a new stake in shares of Select Medical in the second quarter valued at approximately $39,000. DekaBank Deutsche Girozentrale acquired a new position in shares of Select Medical during the 2nd quarter worth approximately $60,000. GAMMA Investing LLC lifted its position in shares of Select Medical by 16.6% during the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider's stock valued at $81,000 after buying an additional 330 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new stake in Select Medical in the 3rd quarter valued at $81,000. 89.48% of the stock is owned by institutional investors and hedge funds.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.